DE69332801D1 - Geschmacksmaskierte pharmazeutische substanzen - Google Patents

Geschmacksmaskierte pharmazeutische substanzen

Info

Publication number
DE69332801D1
DE69332801D1 DE69332801T DE69332801T DE69332801D1 DE 69332801 D1 DE69332801 D1 DE 69332801D1 DE 69332801 T DE69332801 T DE 69332801T DE 69332801 T DE69332801 T DE 69332801T DE 69332801 D1 DE69332801 D1 DE 69332801D1
Authority
DE
Germany
Prior art keywords
taste
pharmaceutical substances
masked pharmaceutical
masked
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332801T
Other languages
English (en)
Other versions
DE69332801T2 (de
Inventor
Robert C Cuca
Roland Scott Harland
Riley, Jr
Yury Lagoviyer
R Saul Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kv Pharmaceutical Co
Original Assignee
Kv Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25529699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69332801(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kv Pharmaceutical Co filed Critical Kv Pharmaceutical Co
Application granted granted Critical
Publication of DE69332801D1 publication Critical patent/DE69332801D1/de
Publication of DE69332801T2 publication Critical patent/DE69332801T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processing Of Meat And Fish (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69332801T 1992-11-30 1993-11-26 Geschmacksmaskierte pharmazeutische substanzen Expired - Fee Related DE69332801T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98297192A 1992-11-30 1992-11-30
PCT/US1993/011517 WO1994012157A1 (en) 1992-11-30 1993-11-26 Tastemasked pharmaceutical materials

Publications (2)

Publication Number Publication Date
DE69332801D1 true DE69332801D1 (de) 2003-04-30
DE69332801T2 DE69332801T2 (de) 2004-01-29

Family

ID=25529699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332801T Expired - Fee Related DE69332801T2 (de) 1992-11-30 1993-11-26 Geschmacksmaskierte pharmazeutische substanzen

Country Status (9)

Country Link
US (1) US5494681A (de)
EP (1) EP0670716B1 (de)
JP (1) JP2949448B2 (de)
KR (2) KR0168715B1 (de)
AU (1) AU5681294A (de)
CA (1) CA2150119C (de)
DE (1) DE69332801T2 (de)
ES (1) ES2194863T3 (de)
WO (1) WO1994012157A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
WO1997003656A1 (fr) * 1995-07-21 1997-02-06 Daiichi Pharmaceutical Co., Ltd. Preparation granulaire et son procede de production
US5820915A (en) * 1996-06-27 1998-10-13 Bioavailability Systems, L.L.C. Method for the preparation of a first-pass effective citrus-derived substance and product thereof
US6124477A (en) * 1996-06-27 2000-09-26 Bioavailability Systems, Llc Anti-first-pass effect compounds
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
WO2000018372A1 (fr) * 1998-09-30 2000-04-06 Taisho Pharmaceutical Co., Ltd. Granules pour preparations orales
KR100768034B1 (ko) * 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물
SI20244A (sl) * 1999-05-19 2000-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Granulacija v talini
EP1064938A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US6953593B2 (en) * 2000-02-01 2005-10-11 Lipoprotein Technologies, Inc. Sustained-release microencapsulated delivery system
DE10010826A1 (de) 2000-03-08 2001-09-13 Basf Ag Verfahren zur Reduktion der Wasserdampfpermeabilität von Folien oder Beschichtungen
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US20020122824A1 (en) * 2001-01-24 2002-09-05 Francisco Cabrera Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
JP4310605B2 (ja) 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
ES2311073T3 (es) * 2001-09-28 2009-02-01 Mcneil-Ppc, Inc. Forma de dosificacion que tiene un nucleo interno y un revestimiento externo.
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
HRP20020924A2 (en) * 2001-11-23 2003-10-31 Glaxo Group Ltd Pharmaceutical composition
KR100913281B1 (ko) 2002-02-21 2009-08-21 오츠카 세이야쿠 가부시키가이샤 서방 제제 및 그의 제조 방법
EP1490031A1 (de) * 2002-03-07 2004-12-29 Vectura Limited Schnell schmelzende multiteilchen-formulierungen für die orale abgabe
AU2003287364A1 (en) * 2002-10-31 2004-06-07 Euro-Celtique S.A. Pharmaceutical identification
FR2852843B1 (fr) * 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
CA2675724C (en) 2003-06-16 2012-12-04 Andrx Pharmaceuticals, Llc Oral extended-release composition
KR101096357B1 (ko) 2003-06-27 2011-12-20 오쓰까 세이야꾸 가부시키가이샤 약물 서방성 입자 및 그 제법
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006017159A1 (en) * 2004-07-09 2006-02-16 Drugtech Corporation Controlled phase composition technology as an improved process for protection of drugs
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
US20070253927A1 (en) * 2006-04-13 2007-11-01 Gwenaelle Jegou Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
US8679541B2 (en) 2007-03-14 2014-03-25 Particle Dynamics International, Llc Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
US9125844B1 (en) 2007-09-25 2015-09-08 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US7964189B1 (en) 2007-09-25 2011-06-21 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US8535660B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US8535659B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
WO2011022737A2 (en) * 2009-08-17 2011-02-24 Waxtabs (Pty) Ltd Tablet manufacture
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
KR101644991B1 (ko) 2015-08-20 2016-08-02 임영호 아가미 제거가 용이한 게 탈갑장치
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
FR3078630B1 (fr) * 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe
FR3079146B1 (fr) * 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954322A (en) * 1958-09-04 1960-09-27 Olin Mathieson Pharmaceuticals
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
DE1216486B (de) * 1964-04-23 1966-05-12 Merck Ag E Verfahren zur Herstellung von Dragees
FR1462193A (fr) * 1965-03-19 1966-12-16 Rhone Poulenc Sa Nouvelles associations à propriétés organoleptiques améliorées
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3806603A (en) * 1969-10-13 1974-04-23 W Gaunt Pharmaceutical carriers of plasticized dried milled particles of hydrated cooked rice endosperm
FR2183546B1 (de) * 1972-05-10 1975-06-20 Servier Lab
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
BE791458A (fr) * 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
US4117801A (en) * 1976-06-10 1978-10-03 Eastman Kodak Company Apparatus for spray coating discrete particles
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
JPS6029682B2 (ja) * 1980-07-11 1985-07-12 山之内製薬株式会社 苦味のない製剤用組成物およびその製造法
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
US4590075A (en) * 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4597970A (en) * 1984-10-05 1986-07-01 Warner-Lambert Company Chewing gum compositions containing novel sweetener delivery systems and method of preparation
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4894233A (en) * 1984-10-05 1990-01-16 Sharma Shri C Novel drug delivery system for decongestants
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
JPS61268619A (ja) * 1985-05-22 1986-11-28 Matsumoto Yushi Seiyaku Kk ポリマ−被覆動物薬製剤
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
DE3625184A1 (de) * 1986-07-25 1988-01-28 Bayer Ag Schwundarm haertbare polyesterharzmassen
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US5004595A (en) * 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US4933190A (en) * 1986-12-23 1990-06-12 Warner-Lambert Co. Multiple encapsulated sweetener delivery system
US4931293A (en) * 1986-12-23 1990-06-05 Warner-Lambert Company Food acid delivery systems containing polyvinyl acetate
US4981698A (en) * 1986-12-23 1991-01-01 Warner-Lambert Co. Multiple encapsulated sweetener delivery system and method of preparation
US4816265A (en) * 1986-12-23 1989-03-28 Warner-Lambert Company Sweetener delivery systems containing polyvinyl acetate
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5059416A (en) * 1989-06-26 1991-10-22 Warner-Lambert Company Zinc compound delivery system with improved taste and texture
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5149775A (en) * 1991-01-25 1992-09-22 Eastman Kodak Company Method for purifying high molecular weight vinylpyridine/styrene polymers from solution
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物

Also Published As

Publication number Publication date
EP0670716B1 (de) 2003-03-26
CA2150119C (en) 2005-03-15
DE69332801T2 (de) 2004-01-29
WO1994012157A1 (en) 1994-06-09
KR0168715B1 (ko) 1999-01-15
EP0670716A4 (de) 1996-10-02
KR970032404A (ko) 1997-07-22
JP2949448B2 (ja) 1999-09-13
KR950703935A (ko) 1995-11-17
AU5681294A (en) 1994-06-22
CA2150119A1 (en) 1994-06-09
JPH08505841A (ja) 1996-06-25
EP0670716A1 (de) 1995-09-13
ES2194863T3 (es) 2003-12-01
US5494681A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
DE69332801T2 (de) Geschmacksmaskierte pharmazeutische substanzen
NO942923L (no) Medikamenter
DE69525148D1 (de) Pharmazeutische formulierung
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
DE69231965D1 (de) Pharmazeutische formulierungen
FI930882A (fi) Farmaceutiska foereningar
FI923581A (fi) Farmaceutisk kombinationsformation
DK0616523T3 (da) Lægemidler
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
NO920067D0 (no) Foradditiv for droevtyggere
NO931831D0 (no) Farmasoeytiske blandinger
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE4294862T1 (de) Pharmazeutische Komposition
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A0 (fi) Farmaceutiska foereningar
DE59310248D1 (de) Pharmazeutische Zubereitung auf Gestagen-Basis
KR950704292A (ko) 약학적 활성을 가진 이환식 화합물(Bicycylic Compounds with Pharmaceutical Activity)
DE69632787D1 (de) Pharmazeutische pellets
DE19681529D2 (de) Pharmazeutische Darreichungsform
FI932768A (fi) Farmaceutiska mjuka gelatinkapslar innehaollande lysinklonixinat och foerfarande foer framstaellning av dessa
DK136492D0 (da) A pharmaceutical formulation
NO931014D0 (no) Farmasoeytisk preparat

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee